BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31078264)

  • 1. α4β2 nicotinic acetylcholine receptor downregulates D
    Acharya S; Kim KM
    Biochem Biophys Res Commun; 2019 Jun; 514(3):665-671. PubMed ID: 31078264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clathrin-mediated endocytosis is responsible for the lysosomal degradation of dopamine D3 receptor.
    Zhang X; Sun N; Zheng M; Kim KM
    Biochem Biophys Res Commun; 2016 Aug; 476(4):245-251. PubMed ID: 27240955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic signaling cascade involved in α4β2 nicotinic acetylcholine receptor-mediated PKCβII activation.
    Acharya S; Kundu D; Choi HJ; Kim KM
    Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118721. PubMed ID: 32304729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.
    Collo G; Bono F; Cavalleri L; Plebani L; Mitola S; Merlo Pich E; Millan MJ; Zoli M; Maskos U; Spano P; Missale C
    Mol Pharmacol; 2013 Jun; 83(6):1176-89. PubMed ID: 23543412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer.
    Bono F; Mutti V; Savoia P; Barbon A; Bellucci A; Missale C; Fiorentini C
    Neurobiol Dis; 2019 Sep; 129():1-12. PubMed ID: 31051233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway.
    Mutti V; Bono F; Tomasoni Z; Bontempi L; Guglielmi A; Bolognin S; Schwamborn JC; Missale C; Fiorentini C
    Mol Neurobiol; 2022 Apr; 59(4):2129-2149. PubMed ID: 35044626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity.
    Bontempi L; Savoia P; Bono F; Fiorentini C; Missale C
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):313-324. PubMed ID: 28187919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Arrestin1 and GPCR kinase2 play permissive roles in Src-mediated endocytosis of α4β2 nicotinic ACh receptors.
    Acharya S; Kundu D; Kim KM
    Br J Pharmacol; 2021 Sep; 178(17):3498-3516. PubMed ID: 33844281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons.
    Sbrini G; Mutti V; Bono F; Tomasoni Z; Fadel D; Missale C; Fiorentini C
    Eur J Pharmacol; 2024 Aug; 976():176678. PubMed ID: 38821163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms involved in epidermal growth factor receptor-mediated inhibition of dopamine D
    Sun N; Zhang X; Guo S; Le HT; Zhang X; Kim KM
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1187-1200. PubMed ID: 29885323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection.
    Bono F; Mutti V; Fiorentini C; Missale C
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32659920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activity.
    Min X; Zhang X; Sun N; Acharya S; Kim KM
    Biochem Pharmacol; 2019 Dec; 170():113675. PubMed ID: 31634457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons.
    Matera C; Bono F; Pelucchi S; Collo G; Bontempi L; Gotti C; Zoli M; De Amici M; Missale C; Fiorentini C; Dallanoce C
    Biochem Pharmacol; 2019 May; 163():154-168. PubMed ID: 30772268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EGF receptor inhibits the signaling of dopamine D
    Sun N; Zhang X; Zhang X; Kim KM
    Biochem Biophys Res Commun; 2017 Aug; 489(4):515-522. PubMed ID: 28579429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Arrestin2 directly or through GRK2 inhibits PKCβII activation in a ubiquitination-dependent manner.
    Zhang X; Zheng M; Sun N; Kim KM
    Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):142-157. PubMed ID: 29054428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons.
    Zhao CJ; Noack C; Brackmann M; Gloveli T; Maelicke A; Heinemann U; Anand R; Braunewell KH
    Mol Cell Neurosci; 2009 Feb; 40(2):280-92. PubMed ID: 19063970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2-mediated ubiquitination of PKCβII is responsible for insulin-induced heterologous desensitization of dopamine D
    Zeng X; Wu C; Cao Y; Li H; Zhang X
    FEBS Lett; 2024 Feb; 598(4):400-414. PubMed ID: 38302840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
    Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
    Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca(2+) dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat.
    Avalos-Fuentes A; Albarrán-Bravo S; Loya-Lopéz S; Cortés H; Recillas-Morales S; Magaña JJ; Paz-Bermúdez F; Rangel-Barajas C; Aceves J; Erlij D; Florán B
    Neurobiol Dis; 2015 Feb; 74():336-46. PubMed ID: 25517101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptors.
    Zheng C; Yang K; Liu Q; Wang MY; Shen J; Vallés AS; Lukas RJ; Barrantes FJ; Wu J
    J Pharmacol Exp Ther; 2010 Nov; 335(2):401-8. PubMed ID: 20688974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.